+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Poisoning Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768042
  • Report
  • April 2019
  • Region: Global
  • 217 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Apotex Inc
  • IQVIA Holdings Inc
  • Novartis AG
  • Shire Plc
  • Wellcome Trust
  • MORE
The global clinical trial report- “2019 Poisoning Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Poisoning. It presents in-depth analysis of Poisoning clinical trials across markets and companies. The research work is for providing complete understanding into trends in Poisoning.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Poisoning clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Poisoning

The research work is prepared through extensive and continuous research on Poisoning trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Poisoning patients are identified
  • The report includes panorama of Poisoning clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Poisoning clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Apotex Inc
  • IQVIA Holdings Inc
  • Novartis AG
  • Shire Plc
  • Wellcome Trust
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Poisoning Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Poisoning Clinical Trials by Region
2.2.2 Average Enrollment of Poisoning Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Poisoning Treatment, 2019

3. Region wise Poisoning Clinical Trials
3.1 Asia Pacific Poisoning Clinical Trials by Country
3.2 Europe Poisoning Clinical Trials by Country
3.3 North America Poisoning Clinical Trials by Country
3.4 Middle East and Africa Poisoning Clinical Trials by Country
3.5 South and Central America Poisoning Clinical Trials by Country

4. Poisoning Clinical Trial Trends
4.1 Start Year wise Poisoning Clinical Trials
4.2 Phase wise Poisoning Clinical Trials
4.3 Trial Status wise Poisoning Clinical Trials
4.4 Trial Type wise Poisoning Clinical Trials

5. Poisoning Average Enrollment Trends
5.1 Average Enrollment in Poisoning Trials by Year
5.2 Average Enrollment in Poisoning Trials by Phase
5.3 Average Enrollment in Poisoning Trials by Status
5.4 Average Enrollment in Poisoning Trials by Type of Trial

6. Companies Participating in Poisoning Clinical Trials
6.1 Poisoning Trials by Sponsor Type
6.2 Poisoning Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Poisoning Trials- Phase 1
7.2 Poisoning Trials- Phase 2
7.3 Poisoning Trials- Phase 3
7.4 Poisoning Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Poisoning Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Poisoning Clinical Trials and Enrolment
Figure 5: Europe - Country wise Poisoning Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Poisoning Clinical Trials and Enrolment
Figure 7: North America - Country wise Poisoning Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Poisoning Clinical Trials and Enrolment
Figure 9: Poisoning Clinical Trials by Phase
Figure 10: Poisoning Clinical Trials by Trial Status
Figure 11: Poisoning Clinical Trials by Type
Figure 12: Poisoning Clinical Trials by Sponsor Type
Figure 13: Poisoning Clinical Trials by Leading Sponsors
Figure 14: Poisoning Average Enrollment by Phase
Figure 15: Poisoning Average Enrollment by Trial Status
Figure 16: Poisoning Average Enrollment by Type
Figure 17: Poisoning- Average Enrolment by Type of Sponsors
Figure 18: Poisoning- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Poisoning Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Poisoning Clinical Trials and Enrolment
Table 5: Europe - Country wise Poisoning Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Poisoning Clinical Trials and Enrolment
Table 7: North America - Country wise Poisoning Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Poisoning Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Poisoning Average Enrollment by Phase
Table 15: Poisoning Average Enrollment by Trial Status
Table 16: Poisoning Average Enrollment by Type
Table 17: Poisoning- Average Enrolment by Type of Sponsors
Table 18: Poisoning- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AFT Pharmaceuticals Pty Ltd
  • Apotex Inc
  • Clinical Pharmacology of Miami Inc
  • DisperSol Technologies LLC
  • Instituto Bioclon SA de CV
  • IQVIA Holdings Inc
  • Novartis AG
  • Shire Plc
  • Teva Pharmaceutical Industries Ltd
  • Wellcome Trust
Note: Product cover images may vary from those shown
Adroll
adroll